NEW YORK, Oct. 3, 2011 /PRNewswire/ -- PLC Medical Systems, Inc. (OTC: PLCSF) today announced that Mark Tauscher, CEO, will present at RetailInvestorConferences.com. DATE:
October 6, 2011TIME:
11:00 AM EDTLINK:
www.retailinvestorconferences.com  > Click the red "register/ watch event now" button.This will be a live, interactive online event where investors are invited to ask the company questions in real-time both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live in real-time, an on-demand archive will be available at the above link as well as on the company's investor relations website (www.plcmed.com , follow links for investors) for 90 days.
It is recommended that investors pre-register to save time and receive event updates.
About PLC Systems Inc.:PLC Systems Inc.,
headquartered in Milford, Mass., is a medical device company
focused on innovative technologies for the cardiac and vascular
markets. PLC's newest product, RenalGuard®, has been developed
to help prevent the onset of contrast induced nephropathy(CIN) in
at-risk patients undergoing certain imaging procedures. It is
already approved for sale in the EU for general fluid balancing.
Two investigator-sponsored European studies have demonstrated
RenalGuard's effectiveness at preventing CIN. RenalGuard is being
studied in a pivotal trial in the U.S., as required for approval by
FDA. The RenalGuard System™ consists of a closed loop,
software-controlled console and single-use sets that physicians and
nurses use for automated matched fluid replacement to minimize
over- or under-hydration of patients during medical procedures
where creating and maintaining high urine outputs is beneficial.
For more information, visit our website at http://w